Home » Healthcare » Pharmaceuticals » Pre-Menstrual Syndrome Treatment Market

Pre-Menstrual Syndrome Treatment Market By Treatment Type (Pharmaceutical treatments, Non-steroidal anti-inflammatory Drugs (NSAIDs), Antidepressants, Hormonal Treatments, Diuretics, Analgesics, Others, Non-pharmaceutical treatments, Dietary Supplements, Lifestyle Modifications, Alternative Therapies, Cognitive Behavioral Therapy (CBT) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Supermarkets and Hypermarkets) By End-User (Hospitals and Clinics, Home Care, Specialty Clinics) By Drug (Analgesics (Pain Killers), Oral Contraceptive Pills (OCPs), Gonadotropin-Releasing Hormone (GnRH), Antidepressants, Ovarian Suppressors, Diuretics, Benzodiazepines) – Growth, Future Prospects And Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Pre-Menstrual Syndrome Treatment Market Size 2023	USD 1524.2 million
Pre-Menstrual Syndrome Treatment Market, CAGR	3.80%
Pre-Menstrual Syndrome Treatment Market Size 2032	USD 2132.15 million

Market Insights

Between 2024 and 2032, the global market for pre-menstrual syndrome treatment is projected to expand at a compound annual growth rate (CAGR) of 3.80%, from an estimated USD 1524.2 million in 2023 to USD 2132.15 million in 2032.
The largest category is pharmaceutical treatments. Non-pharmaceutical treatments, on the other hand, are expected to grow at a strong CAGR.
The retail pharmacies category will expand at a rapid rate of growth.
Throughout the projected period, the CAGR for hospitals and clinics is anticipated to be the highest.
North America controlled the pre-menstrual syndrome treatment market.
Regarding the market share of pre-menstrual syndrome treatment, Europe is expected to come second.
Asia Pacific is expected to experience the fastest growth in the pre-menstrual syndrome treatment industry.
The availability of over-the-counter (OTC) medications, the growing number of women exhibiting PMS symptoms, and public health initiatives promoting awareness of PMS and its treatment are all factors driving the growth of the global market.
The pre-menstrual syndrome treatment market is anticipated to expand due to the development of new, more effective treatments, including non-hormonal and natural options, and the ease with which healthcare providers can be accessed are made possible by the growth of telemedicine.

Executive Summary

Market Definition

Treatment for premenstrual syndrome (PMS) refers to the therapeutic approaches used to reduce emotional, physical, and psychological symptoms that women experience, including bloating, breast tenderness, body pain, exhaustion, mood swings, and anxiety. PMS typically appears at the conclusion of the luteal phase and disappears either right before or right after menstruation. Antidepressants, analgesics, NSAIDs, diuretics, ovarian suppression agents, and hormonal contraceptives are some of the medications used in treatment.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Overview

It is predicted that the pre-menstrual syndrome treatment industry will continue its upward trajectory between 2024 and 2032, growing at a compound annual growth rate (CAGR) of 3.80%. From its projected USD 1524.2 million in 2023 to USD 2132.15 million in 2032, the market will continue to grow.

The shifts in modern life and stress levels may make premenstrual syndrome (PMS) symptoms more severe, which is one of the key causes driving the premenstrual syndrome treatment market’s growth. Because of their desk employment, reliance on technology, and urban life, many women lead sedentary lives with little physical activity. Exercise deficiency can throw hormones out of balance and make PMS symptoms worse. Weight gain brought on by sedentary behavior is linked to an increase in PMS symptoms because of heightened inflammation and hormonal swings. Busy lives frequently result in erratic eating habits and bad dietary decisions, such as consuming a lot of processed food and consuming insufficient amounts of vital nutrients. An inadequate diet might exacerbate PMS symptoms by impacting the hormonal balance of the body.

Along with lifestyle and stress-related issues, the Pre-Menstrual Syndrome (PMS) Treatment Market is growing due to increased public knowledge of the many treatment options available for PMS and related diseases. The knowledge of different drugs has grown, including painkillers, hormone therapies, and antidepressants. It is more common for women to discuss these options with medical specialists. These factors are anticipated to support the development of the pre-menstrual syndrome treatment market.

Segmentation by Treatment Type

Pharmaceutical treatments are the market leader in terms of treatment type. A sizeable portion of the market for PMS therapies is devoted to pharmaceuticals, which aim to reduce the numerous behavioral, emotional, and physical symptoms connected to the illness. Since many women of reproductive age suffer from PMS, there is a constant need for efficient therapeutic solutions. The pharmacological interventions for PMS can be generally divided into multiple types, each focusing on distinct symptoms or underlying causes.
The non-pharmaceutical treatments category will exhibit a sizable CAGR during the projected period. Premenstrual syndrome (PMS) nonpharmaceutical treatments include a range of methods that do not use medication. The goal of these therapies is to lessen the physical, emotional, and behavioral changes that can arise during the luteal phase of the menstrual cycle and are linked to PMS.

Segmentation by Distribution Channel

The retail pharmacies category is projected to develop at a greater CAGR over the forecast period. Due to their widespread presence, retail pharmacies provide a handy point of access for many people pursuing treatment for PMS. Their broad reach is ensured by their frequent locations in suburban, rural, and urban areas.
The hospital pharmacies category will likely register a significant CAGR during forecasting. Hospital pharmacies play a crucial role in the management of PMS by offering essential services that improve patient care, encourage teamwork, guarantee pharmaceutical safety, and support the market’s continued growth for PMS treatments. They play a crucial role in the efficient management of PMS because of their involvement in everything from direct patient interaction to larger contributions to the healthcare system.
Other distribution channels, such as online pharmacies, supermarkets, and hypermarkets, further enhance the need for pre-menstrual syndrome treatment.

Segmentation by End-User

The hospitals and clinics category is projected to grow faster over the projection period. Clinics and hospitals are crucial to the PMS treatment industry. Hospitals are appropriate for severe cases and multidisciplinary treatment approaches since they offer complete, specialist care as well as advanced diagnostic services. Clinics serve a wider range of patients by providing easily accessible, individualized care with an emphasis on primary care and holistic treatment choices.
Other end-users, including home care and specialty clinics, also influence the need for pre-menstrual syndrome treatment.

Segmentation by Region

North America has a large network of healthcare facilities, which makes it the market leader for pre-menstrual syndrome treatment.
Europe is estimated to rank second in pre-menstrual syndrome treatment market size.
It is anticipated that the pre-menstrual syndrome treatment market in Asia Pacific will grow quickly.
The remaining need for pre-menstrual syndrome treatment is met by regions including Latin America, the Middle East, and Africa.

The market for pre-menstrual syndrome treatment has been greatly impacted by advances in medical research, which have improved treatment options and spurred innovation. Discoveries in medicine have increased the understanding of the basic causes and mechanisms of PMS. This include variations in hormone levels, imbalances in neurotransmitters, and hereditary predispositions. These realizations have made it possible to create tailored treatments that target particular PMS symptoms.

North America presently occupies the leading spot in the global market for premenstrual syndrome treatments because of an increase in the condition’s prevalence and awareness among females in this region. Therefore, it is anticipated that there will be a high incidence of treatment. For example, a 2020 study that appeared in the Indian Journal of Research found that the symptoms of premenstrual syndrome cost the US economy $2 billion or 600 million working hours annually. Premenstrual syndrome discomfort affects around 80% of reproductive women at some point in their lives, according to research conducted in 2020 by the British Menopause Society and Women’s Health Concern. Premenstrual syndrome causes discomfort for most women, especially in the first week of the cycle. However, in 5–10% of women, the discomfort is so severe that it causes concerns.

It is projected that the pre-menstrual syndrome treatment market will develop at the fastest rate in the Asia Pacific region. Much of the world’s population resides in Asia Pacific, where nations like China and India have sizable populations. There is a growing need for healthcare services, particularly PMS treatment, as these populations grow and become more urbanized. The Asia Pacific region has seen urbanization and changing lifestyles, which have led to higher stress levels and nutritional changes that are known to affect PMS symptoms. Because of this, PMS is now more common, which has raised the need for remedies.

Key Highlights of the Report

The global pre-menstrual syndrome treatment market is segmented by treatment type, distribution channel, end-user, and region. Pharmaceutical treatments are the market spearhead in terms of treatment type. Retail pharmacies are the top distribution channel category. Hospitals and clinics are anticipated to increase at the highest CAGR during the projection period. North America is seeing the most growth in the pre-menstrual syndrome treatment market.

Premenstrual syndrome affects approximately three out of every four women at some point in their lives. A study that was released in the General Psychiatry Journal 2020 predicted that 90% of women who were fertile would probably have premenstrual symptoms, which could range in intensity from mild to severe. Between 20 and 40 percent of women have premenstrual syndrome. One of the main factors driving the premenstrual syndrome treatment market size is the rising incidence of premenstrual dysphoric disorder around the world. This could be attributed to the busy schedules and sedentary lifestyles of working women. The market is also being driven by the general public’s increasing awareness of luteal phase therapy and other treatment alternatives for PMS and related diseases.

The region with the largest projected global market share for pre-menstrual syndrome treatment is expected to be North America. Compared to other locations, North America has a generally higher awareness of PMS, which results in a larger number of diagnosis and treatment requests from those who are suffering symptoms. Research and development for pharmaceuticals is concentrated in North America. As a result, a variety of therapeutic alternatives are now available, including drugs that are designed to address PMS symptoms particularly. In comparison to other places where PMS symptoms might be less common or less publicly acknowledged, North America may have a larger market due to cultural variables influencing the willingness to seek treatment for symptoms. In addition, it is projected that the Asia Pacific market will grow at the quickest rate. Due to a combination of exports and domestic demand, the pharmaceutical business in Asia Pacific is growing quickly. This expansion makes it simpler to obtain a variety of pharmaceutical goods, such as PMS treatments. Additionally, societal perceptions of open communication and discussion of women’s health issues are gradually changing. As a result of this cultural shift, more women are seeking medical guidance and treatment for PMS symptoms.

Which Key Factors Are Driving The Global Pre-Menstrual Syndrome Treatment Market?

Pre-menstrual syndrome treatments are becoming more widely available as a result of advancements in medical technology that offer improved alternatives for managing the condition, as well as growing awareness of the mental health implications of PMS that support all-encompassing treatment strategies.

What Are The Main Challenges Confronting The Global Pre-Menstrual Syndrome Treatment Market?

Natural and alternative remedies are preferred over pharmaceutical ones, which is one of the major challenges affecting the premenstrual syndrome treatment sector. Some women might not be able to pay for more costly treatment options.

What Market Opportunities Exist For Pre-Menstrual Syndrome Treatment Globally?

The market for pre-menstrual syndrome treatment is expanding due to several causes, including the rising demand for supplements and nutraceuticals for PMS management and the need to align PMS treatments with more general wellness and health trends.

Market Drivers

Advancements in Medical Research

The fundamental mechanisms and causes of PMS, including hormone fluctuations, neurotransmitter abnormalities, and hereditary factors, have become better understood via research. As a result of this increased understanding, more effective treatments can be created by focusing on particular components of the illness with tailored therapies. Novel drugs and treatment modalities for PMS are frequently developed as a result of research advancements. As an example, the treatment of severe PMS symptoms has been effectively achieved with the use of selective serotonin reuptake inhibitors (SSRIs), which alter neurotransmitter levels. In a similar vein, nutritional supplements and hormone therapy have been shown by science to be effective treatment alternatives.

Extensive research-driven clinical trials offer vital information on the safety and effectiveness of novel medicines. This proof is necessary to secure regulatory permission and provider acceptance, which will enable market adoption. The development of biomarkers and genetics has made it possible to treat PMS patients individually. Biomarker analysis and genetic testing can assist in individualized therapy planning, maximizing therapeutic benefits and reducing adverse effects. These factors are propelling the growth of the pre-menstrual syndrome treatment industry.

Market Restraints

Lack of Standardized Treatment Guidelines

Healthcare professionals’ diagnoses and treatments of PMS are inconsistent in the absence of set criteria. This causes a lack of consistency in treatment modalities, which can be perplexing to patients as well as healthcare professionals. Patients may find it difficult to decide on the best course of action because different medical specialists may suggest different treatments. The results of treatment could differ greatly between patients because there is a lack of uniformity. Without criteria, it might be challenging to determine which therapies consistently yield the best outcomes, even though some may be more effective than others. Both patients and healthcare professionals may become frustrated as a result of this discrepancy. From a commercial standpoint, the lack of established protocols may impede the advancement of novel interventions and cures. Researchers and pharmaceutical firms may be less likely to fund PMS.

Opportunities

Development of Innovative Therapies

NSAIDs for pain management and hormonal contraceptives for hormone regulation are common traditional therapies for PMS. On the other hand, novel treatments can more specifically target particular hormonal imbalances or metabolic pathways linked to PMS. This could entail receiving therapies that alter neurotransmitters like serotonin, which is linked to PMS symptoms and regulates mood. Personalized therapy techniques may result from advances in recognizing individual differences in hormone and genetic makeup. For example, genetic testing may be able to pinpoint particular mutations or variants that make people more susceptible to severe PMS symptoms, enabling the development of customized treatments. Mobile apps, wearable tech, and digital health platforms can all offer individualized feedback and real-time symptom monitoring. These technologies make it possible to continuously monitor menstrual cycles and symptoms, which makes it easier to intervene early and modify treatment plans individually. Acupuncture, herbal supplements, and other alternative therapies are becoming more and more popular as PMS remedies. Research and clinical trial innovations can confirm the effectiveness and safety of these methods, giving patients more choices. These factors will create opportunities for the pre-menstrual syndrome treatment sector.

Competitive Landscape

Key Players

A number of significant players dominate the highly competitive global market for pre-menstrual syndrome treatment. A handful of the top market players are shown below, together with their respective market shares:

AstraZeneca plc
BASF Corporation
Bayer AG
Shionogi Inc.
Dr. Reddy’s Laboratories Ltd
GlaxoSmithKline Plc
H. Lundbeck A/S
ABBVIE INC.
Eli Lilly and Company
Pfizer Inc.
Others

In order to stay competitive, these organizations give priority to product innovation, expansion of their distribution channels, and mergers and acquisitions.

By creating cutting-edge ideas and goods, the foremost manufacturers in the global market for pre-menstrual syndrome treatment consistently strive to stay one step ahead of the competition.

In September 2023, Aiming to improve the treatment options for people with anxiety, depression, and other central nervous system (CNS) disorders, Vistagen, a late-stage biopharmaceutical company, announced that one of its five experimental neuroactive nasal sprays, PH80, showed statistically significant improvement over placebo in an exploratory Phase 2A study for the acute management of premenstrual dysphoric disorder (PMDD) symptoms, including depressive symptoms and behavioral and physical symptoms.

In June 2021, According to Movant Sciences and Pfizer, Inc., MYFEMBREE (religieux 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) is the first once-daily medication approved by the FDA for the treatment of heavy menstrual bleeding linked to uterine fibroids in premenopausal women. The treatment course can last up to 24 months. According to the conditions of their previously disclosed partnership, Movant and Pfizer would jointly market MYFEMBREE in the United States. The release of MYFEMBREE is planned.

How are Companies Performing in the Pre-Menstrual Syndrome Treatment Market?

Pharmaceutical companies are making significant investments in R&D to discover novel therapies that treat the range of pre-menstrual syndrome symptoms. For example, a well-known healthcare company introduced a novel nutritional supplement intended especially to reduce PMS symptoms. This medication uses a combination of natural substances to help with mood stability and reduce bloating.

Pharmaceutical companies are conducting research and development for products such as oral medications that do not require surgery. The US Food and Drug Administration (FDA) approved AbbVie and Neurocrine Biosciences, Inc.’s ORIAHN (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) in May 2020. For the treatment of heavy menstrual bleeding linked to uterine fibroids in premenopausal women, ORIAHNN is the first FDA-approved oral pharmaceutical alternative without surgery.

Significant companies are launching systematic campaigns to meet the increasing requirement for products for hormonal replacement treatment. I-MAB Biopharma Co., Ltd. and Jumpcan Pharmaceutical Group collaborated on the research and marketing of eftansomatropin alfa (TJ101) in China in November 2021. A phase 3 clinical trial is underway to treat pediatric growth hormone deficit with TJ101, a long-acting recombinant human growth hormone. It is anticipated that this partnership will improve its standing in the sector for hormonal replacement treatment. Furthermore, Pfizer’s NGENLA was authorized by Korea’s Ministry of Food and Drug Safety in February 2023 to treat growth hormone insufficiency.

Summary of Key Findings

The need for the pre-menstrual syndrome treatment sector is supported by improved capabilities and infrastructure in hospitals, clinics, and healthcare facilities.
The market is segmented by treatment type, distribution channel, end-user, and region.
In the market, the most prevalent treatment type is pharmaceutical treatment.
Retail pharmacies are the foremost distribution channel category.
Hospitals and clinics are expected to grow fastest in terms of CAGR during the forecast period.
In terms of market development, North America is a leader; the market is highly competitive with key players including AstraZeneca plc, BASF Corporation, Bayer AG, Shionogi Inc., Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, H. Lundbeck A/S, ABBVIE INC., Eli Lilly and Company, Pfizer Inc., and Others.

Future Outlook

The pre-menstrual syndrome treatment industry is expected to increase significantly in North America, and its outlook is positive worldwide.
Technological advancements in medicine are anticipated to be major drivers of the industry.
Side effects of hormonal treatments are the main barriers to the industry’s expansion in the pre-menstrual syndrome treatment sector.
Developing new products, reaching a wider market, and maintaining competitive prices are all necessary for major businesses to stay ahead of the competition.

How the Credence Research Pre-Menstrual Syndrome Treatment Market Report Can Help CXOs

The Credence Research Pre-Menstrual Syndrome Treatment Market Report provides CXOs with an extensive market overview and comprises the following:

Market size and growth forecast: The study offers comprehensive market estimations for pre-menstrual syndrome treatment globally, broken down by treatment type, distribution channel, end-user, and region. Furthermore, the report includes market forecasts through 2032, derived from key drivers and trends.
Market segmentation: The pre-menstrual syndrome treatment market is divided into segments by treatment type, distribution channel, end-user, and region in the research report. This segmentation helps CXOs understand the market and the opportunities inside each area in great depth.
Competitive landscape: The study report provides a thorough analysis of the leading businesses in the pre-menstrual syndrome treatment sector, together with details on their revenue streams, product lines, and business strategies. With this information, CXOs can assess and identify their competitors.
Key trends and drivers: The study report analyzes and highlights the key developments and elements driving the market for pre-menstrual syndrome treatment. CXOs can utilize this information to make well-informed choices regarding their plans and investments.

The Credence Research Pre-Menstrual Syndrome Treatment Market Report provides CXOs with insights that they may utilize to:

Identify growth opportunities: This analysis is likely to help CXOs find fresh growth prospects in the pre-menstrual syndrome treatment sector. For example, the research recognizes the increasing requirement for pre-menstrual syndrome treatment from hospitals and clinics as a crucial opportunity.
Make informed investment decisions: The study aids CXOs in making informed decisions about pre-menstrual syndrome treatment. For example, it delivers information on the key variables to consider while picking pre-menstrual syndrome treatment solutions and evaluating suppliers.
Develop competitive strategies: CXOs can utilize the research report to establish competitive strategies for their pre-menstrual syndrome treatment firms. The study paper explores the primary tactics employed by pre-menstrual syndrome treatment providers to set themselves apart from their rivals.
Track market developments: By tracking market advancements, this research report could assist CXOs in remaining ahead of the curve. For example, it provides information about the latest advancements and patterns in the pre-menstrual syndrome treatment industry.

The Credence Research Pre-Menstrual Syndrome Treatment Market Report is helpful for CXOs who want to learn more about the market and identify potential opportunities.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Segmentation

By Treatment Type
- Pharmaceutical treatments
  - Non-steroidal anti-inflammatory Drugs (NSAIDs)
  - Antidepressants
  - Hormonal Treatments
  - Diuretics
  - Analgesics
  - Others
- Non-pharmaceutical treatments
  - Dietary Supplements
  - Lifestyle Modifications
  - Alternative Therapies
  - Cognitive Behavioral Therapy (CBT)
- By Distribution Channel
  - Retail Pharmacies
  - Hospital Pharmacies
  - Online Pharmacies
  - Supermarkets and Hypermarkets
- By End-User
  - Hospitals and Clinics
  - Home Care
  - Specialty Clinics
- By Region
  - North America
    - U.S.
    - Canada
    - Mexico
  - Europe
    - Germany
    - France
    - UK
    - Italy
    - Spain
    - Rest of Europe
  - Asia Pacific
    - China
    - Japan
    - India
    - South Korea
    - South-east Asia
    - Rest of Asia Pacific
  - Latin America
    - Brazil
    - Argentina
    - Rest of Latin America
  - Middle East & Africa
    - GCC Countries
    - South Africa
    - The Rest of the Middle East and Africa

Adjacent Markets

Several adjacent markets in the pre-menstrual syndrome treatment market have high revenue growth opportunities. The key adjacent markets for the pre-menstrual syndrome treatment market –

Adjacent Markets
Women’s Health Supplements	Endocrine Disorder Treatments	Medical Devices for Women’s Health
Hormonal Disorder Treatments	Telemedicine and Digital Health	Personal Care Products
Mental Health Treatments	Alternative and Complementary Medicine	Healthcare IT Solutions

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

2. Executive Summary

2.1. Market Snapshot: Global Pre-Menstrual Syndrome Treatment Market

2.1.1. Global Pre-Menstrual Syndrome Treatment Market, By Treatment Type

2.1.2. Global Pre-Menstrual Syndrome Treatment Market, By Distribution Channel

2.1.3. Global Pre-Menstrual Syndrome Treatment Market, By End-User

2.1.4. Global Pre-Menstrual Syndrome Treatment Market, By Region

2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Pre-Menstrual Syndrome Treatment Market Value, 2019-2032, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Pre-Menstrual Syndrome Treatment Market Drivers

3.2.2. Pre-Menstrual Syndrome Treatment Market Restraints

3.2.3. Pre-Menstrual Syndrome Treatment Market Opportunities

3.2.4. Major Pre-Menstrual Syndrome Treatment Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Treatment Type

3.5.2. Distribution Channel

3.5.3. End-User

3.5.4. Geography

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2023

4.1.1. Global Pre-Menstrual Syndrome Treatment Market: Company Market Share, Value 2023

4.1.2. Global Pre-Menstrual Syndrome Treatment Market: Top 6 Company Market Share, Value 2023

4.1.3. Global Pre-Menstrual Syndrome Treatment Market: Top 3 Company Market Share, Value 2023

4.2. Global Pre-Menstrual Syndrome Treatment Market: Company Revenue Share Analysis, 2023

4.3. Company Assessment Metrics, 2023

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2023

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Pre-Menstrual Syndrome Treatment Market

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2023

6.1. Company market share of key players, 2023

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Pre-Menstrual Syndrome Treatment Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

8. Global Pre-Menstrual Syndrome Treatment Market, By Treatment Type

8.1. Global Pre-Menstrual Syndrome Treatment Market Overview, by Treatment Type

8.1.1. Global Pre-Menstrual Syndrome Treatment Market Revenue Share, By Treatment Type, 2023 Vs 2032 (in %)

8.2. Pharmaceutical Treatments

8.2.1. Global Pre-Menstrual Syndrome Treatment Market, By Pharmaceutical Treatments, By Region, 2019-2032 (US$ Mn)

8.2.2. Market Dynamics for Pharmaceutical Treatments

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Non-Pharmaceutical Treatments

8.3.1. Global Pre-Menstrual Syndrome Treatment Market, By Non-Pharmaceutical Treatments, By Region, 2019-2032 (US$ Mn)

8.3.2. Market Dynamics for Non-Pharmaceutical Treatments

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

9. Global Pre-Menstrual Syndrome Treatment Market, By Distribution Channel

9.1. Global Pre-Menstrual Syndrome Treatment Market Overview, by Distribution Channel

9.1.1. Global Pre-Menstrual Syndrome Treatment Market Revenue Share, By Distribution Channel, 2023 Vs 2032 (in %)

9.2. Retail Pharmacies

9.2.1. Global Pre-Menstrual Syndrome Treatment Market, By Retail Pharmacies, By Region, 2019-2032 (US$ Mn)

9.2.2. Market Dynamics for Retail Pharmacies

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Hospital Pharmacies

9.3.1. Global Pre-Menstrual Syndrome Treatment Market, By Hospital Pharmacies, By Region, 2019-2032 (US$ Mn)

9.3.2. Market Dynamics for Hospital Pharmacies

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Online Pharmacies

9.4.1. Global Pre-Menstrual Syndrome Treatment Market, By Online Pharmacies, By Region, 2019-2032 (US$ Mn)

9.4.2. Market Dynamics for Online Pharmacies

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Supermarkets and Hypermarkets

9.5.1. Global Pre-Menstrual Syndrome Treatment Market, By Supermarkets and Hypermarkets, By Region, 2019-2032 (US$ Mn)

9.5.2. Market Dynamics for Supermarkets and Hypermarkets

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

10. Global Pre-Menstrual Syndrome Treatment Market, By End-User

10.1. Global Pre-Menstrual Syndrome Treatment Market Overview, by End-User

10.1.1. Global Pre-Menstrual Syndrome Treatment Market Revenue Share, By End-User, 2023 Vs 2032 (in %)

10.2. Hospitals and Clinics

10.2.1. Global Pre-Menstrual Syndrome Treatment Market, By Hospitals and Clinics, By Region, 2019-2032 (US$ Mn)

10.2.2. Market Dynamics for Hospitals and Clinics

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Home Care

10.3.1. Global Pre-Menstrual Syndrome Treatment Market, By Home Care, By Region, 2019-2032 (US$ Mn)

10.3.2. Market Dynamics for Home Care

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

10.4. Specialty Clinics

10.4.1. Global Pre-Menstrual Syndrome Treatment Market, By Specialty Clinics, By Region, 2019-2032 (US$ Mn)

10.4.2. Market Dynamics for Specialty Clinics

10.4.2.1. Drivers

10.4.2.2. Restraints

10.4.2.3. Opportunities

10.4.2.4. Trends

11. Global Pre-Menstrual Syndrome Treatment Market, By Region

11.1. Global Pre-Menstrual Syndrome Treatment Market Overview, by Region

11.1.1. Global Pre-Menstrual Syndrome Treatment Market, By Region, 2023 Vs 2032 (in%)

11.2. Treatment Type

11.2.1. Global Pre-Menstrual Syndrome Treatment Market, By Treatment Type, 2019-2032 (US$ Mn)

11.3. Distribution Channel

11.3.1. Global Pre-Menstrual Syndrome Treatment Market, By Distribution Channel, 2019-2032 (US$ Mn)

11.4. End-User

11.4.1. Global Pre-Menstrual Syndrome Treatment Market, By End-User, 2019-2032 (US$ Mn)

12. North America Pre-Menstrual Syndrome Treatment Market Analysis

12.1. Overview

12.1.1. Market Dynamics for North America

12.1.1.1. Drivers

12.1.1.2. Restraints

12.1.1.3. Opportunities

12.1.1.4. Trends

12.2. North America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2032(US$ Mn)

12.2.1. Overview

12.2.2. SRC Analysis

12.3. North America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2032(US$ Mn)

12.3.1. Overview

12.3.2. SRC Analysis

12.4. North America Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2032(US$ Mn)

12.4.1. Overview

12.4.2. SRC Analysis

12.5. North America Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2032 (US$ Mn)

12.5.1. North America Pre-Menstrual Syndrome Treatment Market, by Country, 2023 Vs 2032 (in%)

12.5.2. U.S.

12.5.3. Canada

12.5.4. Mexico

13. Europe Pre-Menstrual Syndrome Treatment Market Analysis

13.1. Overview

13.1.1. Market Dynamics for Europe

13.1.1.1. Drivers

13.1.1.2. Restraints

13.1.1.3. Opportunities

13.1.1.4. Trends

13.2. Europe Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2032(US$ Mn)

13.2.1. Overview

13.2.2. SRC Analysis

13.3. Europe Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2032(US$ Mn)

13.3.1. Overview

13.3.2. SRC Analysis

13.4. Europe Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2032(US$ Mn)

13.4.1. Overview

13.4.2. SRC Analysis

13.5. Europe Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2032 (US$ Mn)

13.5.1. Europe Pre-Menstrual Syndrome Treatment Market, by Country, 2023 Vs 2032 (in%)

13.5.2. UK

13.5.3. France

13.5.4. Germany

13.5.5. Italy

13.5.6. Spain

13.5.7. Benelux

13.5.8. Russia

13.5.9. Rest of Europe

14. Asia Pacific Pre-Menstrual Syndrome Treatment Market Analysis

14.1. Overview

14.1.1. Market Dynamics for Asia Pacific

14.1.1.1. Drivers

14.1.1.2. Restraints

14.1.1.3. Opportunities

14.1.1.4. Trends

14.2. Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2032(US$ Mn)

14.2.1. Overview

14.2.2. SRC Analysis

14.3. Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2032(US$ Mn)

14.3.1. Overview

14.3.2. SRC Analysis

14.4. Asia Pacific Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2032(US$ Mn)

14.4.1. Overview

14.4.2. SRC Analysis

14.5. Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2032 (US$ Mn)

14.5.1. Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Country, 2023 Vs 2032 (in%)

14.5.2. China

14.5.3. Japan

14.5.4. India

14.5.5. South Korea

14.5.6. South East Asia

14.5.7. Rest of Asia Pacific

15. Latin America Pre-Menstrual Syndrome Treatment Market Analysis

15.1. Overview

15.1.1. Market Dynamics for Latin America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. Latin America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2032(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. Latin America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2032(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. Latin America Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2032(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. Latin America Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2032 (US$ Mn)

15.5.1. Latin America Pre-Menstrual Syndrome Treatment Market, by Country, 2023 Vs 2032 (in%)

15.5.2. Brazil

15.5.3. Argentina

15.5.4. Rest of Latin America

16. Middle East Pre-Menstrual Syndrome Treatment Market Analysis

16.1. Overview

16.1.1. Market Dynamics for Middle East

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Middle East Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2032(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Middle East Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2032(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Middle East Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2032(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Middle East Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2032 (US$ Mn)

16.5.1. Middle East Pre-Menstrual Syndrome Treatment Market, by Country, 2023 Vs 2032 (in%)

16.5.2. UAE

16.5.3. Saudi Arabia

16.5.4. Rest of Middle East

17. Africa Pre-Menstrual Syndrome Treatment Market Analysis

17.1. Overview

17.1.1. Market Dynamics for Africa

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2032(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2032(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2032(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Africa Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2032 (US$ Mn)

17.5.1. Africa Pre-Menstrual Syndrome Treatment Market, by Country, 2023 Vs 2032 (in%)

17.5.2. South Africa

17.5.3. Egypt

17.5.4. Rest of Africa

18. Company Profiles

18.1. AstraZeneca plc

18.1.1. Company Overview

18.1.2. Products/Services Portfolio

18.1.3. Geographical Presence

18.1.4. SWOT Analysis

18.1.5. Financial Summary

18.1.5.1. Market Revenue and Net Profit (2019-2023)

18.1.5.2. Business Segment Revenue Analysis

18.1.5.3. Geographical Revenue Analysis

18.2. BASF Corporation

18.3. Bayer AG

18.4. Shionogi Inc.

18.5. Dr. Reddy’s Laboratories Ltd

18.6. GlaxoSmithKline Plc

18.7. H. Lundbeck A/S

18.8. ABBVIE INC.

18.9. Eli Lilly and Company

18.10. Pfizer Inc.

18.11. Others

19. Research Methodology

19.1. Research Methodology

19.2. Phase I – Secondary Research

19.3. Phase II – Data Modelling

19.3.1. Company Share Analysis Model

19.3.2. Revenue Based Modelling

19.4. Phase III – Primary Research

19.5. Research Limitations

19.5.1. Assumptions

List of Figures

FIG. 1 Global Pre-Menstrual Syndrome Treatment Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Pre-Menstrual Syndrome Treatment Market Segmentation

FIG. 4 Global Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2023 (US$ Mn)

FIG. 5 Global Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2023 (US$ Mn)

FIG. 6 Global Pre-Menstrual Syndrome Treatment Market, by End-User, 2023 (US$ Mn)

FIG. 7 Global Pre-Menstrual Syndrome Treatment Market, by Geography, 2023 (US$ Mn)

FIG. 8 Attractive Investment Proposition, by Treatment Type, 2023

FIG. 9 Attractive Investment Proposition, by Distribution Channel, 2023

FIG. 10 Attractive Investment Proposition, by End-User, 2023

FIG. 11 Attractive Investment Proposition, by Geography, 2023

FIG. 12 Global Market Share Analysis of Key Pre-Menstrual Syndrome Treatment Market Manufacturers, 2023

FIG. 13 Global Market Positioning of Key Pre-Menstrual Syndrome Treatment Market Manufacturers, 2023

FIG. 14 Global Pre-Menstrual Syndrome Treatment Market Value Contribution, By Treatment Type, 2023 & 2032 (Value %)

FIG. 15 Global Pre-Menstrual Syndrome Treatment Market, by Pharmaceutical Treatments, Value, 2019-2032 (US$ Mn)

FIG. 16 Global Pre-Menstrual Syndrome Treatment Market, by Non-Pharmaceutical Treatments, Value, 2019-2032 (US$ Mn)

FIG. 17 Global Pre-Menstrual Syndrome Treatment Market Value Contribution, By Distribution Channel, 2023 & 2032 (Value %)

FIG. 18 Global Pre-Menstrual Syndrome Treatment Market, by Retail Pharmacies, Value, 2019-2032 (US$ Mn)

FIG. 19 Global Pre-Menstrual Syndrome Treatment Market, by Hospital Pharmacies, Value, 2019-2032 (US$ Mn)

FIG. 20 Global Pre-Menstrual Syndrome Treatment Market, by Online Pharmacies, Value, 2019-2032 (US$ Mn)

FIG. 21 Global Pre-Menstrual Syndrome Treatment Market, by Supermarkets and Hypermarkets, Value, 2019-2032 (US$ Mn)

FIG. 22 Global Pre-Menstrual Syndrome Treatment Market Value Contribution, By End-User, 2023 & 2032 (Value %)

FIG. 23 Global Pre-Menstrual Syndrome Treatment Market, by Hospitals and Clinics, Value, 2019-2032 (US$ Mn)

FIG. 24 Global Pre-Menstrual Syndrome Treatment Market, by Home Care, Value, 2019-2032 (US$ Mn)

FIG. 25 Global Pre-Menstrual Syndrome Treatment Market, by Specialty Clinics, Value, 2019-2032 (US$ Mn)

FIG. 26 North America Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 27 U.S. Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 28 Canada Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 29 Mexico Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 30 Europe Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 31 Germany Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 32 France Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 33 U.K. Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 34 Italy Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 35 Spain Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 36 Benelux Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 37 Russia Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 38 Rest of Europe Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 39 Asia Pacific Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 40 China Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 41 Japan Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 42 India Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 43 South Korea Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 44 South-East Asia Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 45 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 46 Latin America Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 47 Brazil Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 48 Argentina Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 49 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 50 Middle East Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 51 UAE Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 52 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 53 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 54 Africa Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 55 South Africa Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 56 Egypt Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

FIG. 57 Rest of Africa Pre-Menstrual Syndrome Treatment Market, 2019-2032 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Pre-Menstrual Syndrome Treatment Market

TABLE 2 Global Pre-Menstrual Syndrome Treatment Market: Market Drivers Impact Analysis

TABLE 3 Global Pre-Menstrual Syndrome Treatment Market: Market Restraints Impact Analysis

TABLE 4 Global Pre-Menstrual Syndrome Treatment Market, by Competitive Benchmarking, 2023

TABLE 5 Global Pre-Menstrual Syndrome Treatment Market, by Geographical Presence Analysis, 2023

TABLE 6 Global Pre-Menstrual Syndrome Treatment Market, by Key Strategies Analysis, 2023

TABLE 7 Global Pre-Menstrual Syndrome Treatment Market, by Pharmaceutical Treatments, By Region, 2019-2023 (US$ Mn)

TABLE 8 Global Pre-Menstrual Syndrome Treatment Market, by Pharmaceutical Treatments, By Region, 2024-2032 (US$ Mn)

TABLE 9 Global Pre-Menstrual Syndrome Treatment Market, by Non-Pharmaceutical Treatments, By Region, 2019-2023 (US$ Mn)

TABLE 10 Global Pre-Menstrual Syndrome Treatment Market, by Non-Pharmaceutical Treatments, By Region, 2024-2032 (US$ Mn)

TABLE 11 Global Pre-Menstrual Syndrome Treatment Market, by Retail Pharmacies, By Region, 2019-2023 (US$ Mn)

TABLE 12 Global Pre-Menstrual Syndrome Treatment Market, by Retail Pharmacies, By Region, 2024-2032 (US$ Mn)

TABLE 13 Global Pre-Menstrual Syndrome Treatment Market, by Hospital Pharmacies, By Region, 2019-2023 (US$ Mn)

TABLE 14 Global Pre-Menstrual Syndrome Treatment Market, by Hospital Pharmacies, By Region, 2024-2032 (US$ Mn)

TABLE 15 Global Pre-Menstrual Syndrome Treatment Market, by Online Pharmacies, By Region, 2019-2023 (US$ Mn)

TABLE 16 Global Pre-Menstrual Syndrome Treatment Market, by Online Pharmacies, By Region, 2024-2032 (US$ Mn)

TABLE 17 Global Pre-Menstrual Syndrome Treatment Market, by Supermarkets and Hypermarkets, By Region, 2019-2023 (US$ Mn)

TABLE 18 Global Pre-Menstrual Syndrome Treatment Market, by Supermarkets and Hypermarkets, By Region, 2024-2032 (US$ Mn)

TABLE 19 Global Pre-Menstrual Syndrome Treatment Market, by Hospitals and Clinics, By Region, 2019-2023 (US$ Mn)

TABLE 20 Global Pre-Menstrual Syndrome Treatment Market, by Hospitals and Clinics, By Region, 2024-2032 (US$ Mn)

TABLE 21 Global Pre-Menstrual Syndrome Treatment Market, by Home Care, By Region, 2019-2023 (US$ Mn)

TABLE 22 Global Pre-Menstrual Syndrome Treatment Market, by Home Care, By Region, 2024-2032 (US$ Mn)

TABLE 23 Global Pre-Menstrual Syndrome Treatment Market, by Specialty Clinics, By Region, 2019-2023 (US$ Mn)

TABLE 24 Global Pre-Menstrual Syndrome Treatment Market, by Specialty Clinics, By Region, 2024-2032 (US$ Mn)

TABLE 25 Global Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 26 Global Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 27 Global Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 28 Global Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 29 Global Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 30 Global Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 31 Global Pre-Menstrual Syndrome Treatment Market, by Region, 2019-2023 (US$ Mn)

TABLE 32 Global Pre-Menstrual Syndrome Treatment Market, by Region, 2024-2032 (US$ Mn)

TABLE 33 North America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 34 North America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 35 North America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 36 North America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 37 North America Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 38 North America Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 39 North America Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2023 (US$ Mn)

TABLE 40 North America Pre-Menstrual Syndrome Treatment Market, by Country, 2024-2032 (US$ Mn)

TABLE 41 United States Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 42 United States Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 43 United States Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 44 United States Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 45 United States Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 46 United States Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 47 Canada Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 48 Canada Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 49 Canada Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 50 Canada Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 51 Canada Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 52 Canada Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 53 Mexico Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 54 Mexico Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 55 Mexico Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 56 Mexico Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 57 Mexico Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 58 Mexico Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 59 Europe Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 60 Europe Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 61 Europe Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 62 Europe Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 63 Europe Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 64 Europe Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 65 Europe Pre-Menstrual Syndrome Treatment Market, by Country, 2019-2023 (US$ Mn)

TABLE 66 Europe Pre-Menstrual Syndrome Treatment Market, by Country, 2024-2032 (US$ Mn)

TABLE 67 Germany Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 68 Germany Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 69 Germany Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 70 Germany Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 71 Germany Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 72 Germany Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 73 France Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 74 France Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 75 France Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 76 France Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 77 France Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 78 France Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 79 United Kingdom Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 80 United Kingdom Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 81 United Kingdom Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 82 United Kingdom Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 83 United Kingdom Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 84 United Kingdom Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 85 Italy Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 86 Italy Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 87 Italy Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 88 Italy Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 89 Italy Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 90 Italy Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 91 Spain Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 92 Spain Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 93 Spain Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 94 Spain Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 95 Spain Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 96 Spain Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 97 Benelux Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 98 Benelux Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 99 Benelux Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 100 Benelux Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 101 Benelux Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 102 Benelux Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 103 Russia Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 104 Russia Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 105 Russia Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 106 Russia Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 107 Russia Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 108 Russia Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 109 Rest of Europe Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 110 Rest of Europe Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 111 Rest of Europe Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 112 Rest of Europe Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 113 Rest of Europe Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 114 Rest of Europe Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 115 Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 116 Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 117 Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 118 Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 119 Asia Pacific Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 120 Asia Pacific Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 121 China Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 122 China Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 123 China Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 124 China Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 125 China Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 126 China Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 127 Japan Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 128 Japan Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 129 Japan Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 130 Japan Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 131 Japan Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 132 Japan Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 133 India Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 134 India Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 135 India Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 136 India Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 137 India Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 138 India Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 139 South Korea Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 140 South Korea Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 141 South Korea Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 142 South Korea Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 143 South Korea Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 144 South Korea Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 145 South-East Asia Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 146 South-East Asia Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 147 South-East Asia Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 148 South-East Asia Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 149 South-East Asia Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 150 South-East Asia Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 151 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 152 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 153 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 154 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 155 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 156 Rest of Asia Pacific Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 157 Latin America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 158 Latin America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 159 Latin America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 160 Latin America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 161 Latin America Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 162 Latin America Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 163 Brazil Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 164 Brazil Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 165 Brazil Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 166 Brazil Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 167 Brazil Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 168 Brazil Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 169 Argentina Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 170 Argentina Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 171 Argentina Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 172 Argentina Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 173 Argentina Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 174 Argentina Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 175 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 176 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 177 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 178 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 179 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 180 Rest of Latin America Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 181 Middle East Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 182 Middle East Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 183 Middle East Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 184 Middle East Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 185 Middle East Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 186 Middle East Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 187 UAE Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 188 UAE Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 189 UAE Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 190 UAE Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 191 UAE Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 192 UAE Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 193 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 194 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 195 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 196 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 197 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 198 Saudi Arabia Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 199 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 200 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 201 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 202 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 203 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 204 Rest of Middle East Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 205 Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 206 Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 207 Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 208 Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 209 Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 210 Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 211 South Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 212 South Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 213 South Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 214 South Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 215 South Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 216 South Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 217 Egypt Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 218 Egypt Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 219 Egypt Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 220 Egypt Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 221 Egypt Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 222 Egypt Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

TABLE 223 Rest of Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2019-2023 (US$ Mn)

TABLE 224 Rest of Africa Pre-Menstrual Syndrome Treatment Market, by Treatment Type, 2024-2032 (US$ Mn)

TABLE 225 Rest of Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2019-2023 (US$ Mn)

TABLE 226 Rest of Africa Pre-Menstrual Syndrome Treatment Market, by Distribution Channel, 2024-2032 (US$ Mn)

TABLE 227 Rest of Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2019-2023 (US$ Mn)

TABLE 228 Rest of Africa Pre-Menstrual Syndrome Treatment Market, by End-User, 2024-2032 (US$ Mn)

Frequently Asked Questions

How much does the global market currently hold for pre-menstrual syndrome treatment?

In 2023, the pre-menstrual syndrome treatment market was estimated to be worth USD 1524.2 million.

What is the pre-menstrual syndrome treatment market’s projected growth rate between 2024 and 2032?

The pre-menstrual syndrome treatment market is anticipated to increase at a CAGR of 3.80% from 2024 to 2032, reaching USD 2132.15 million in 2032.

In terms of treatment type, which market category is leading?

Pharmaceutical treatments are the most popular treatment type category.

Regarding the distribution channel, which market category is in the lead?

The noteworthy distribution channel segment is retail pharmacies.

Which end-user category is anticipated to grow at the fastest rate throughout the forecast period?

During the forecast timeframe, the hospitals and clinics are expected to have the strongest estimated CAGR.

In which region is the market for pre-menstrual syndrome treatment expanding?

North America ruled the pre-menstrual syndrome treatment market.

Who are the main players in the global pre-menstrual syndrome treatment industry?

The top players include AstraZeneca plc, BASF Corporation, Bayer AG, Shionogi Inc., Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, H. Lundbeck A/S, ABBVIE INC., Eli Lilly and Company, Pfizer Inc., and others.

Which market factors are the primary drivers of the pre-menstrual syndrome treatment industry?

The focus of government agencies and nonprofits on women’s health issues, along with pharmaceutical companies’ efforts to discover and sell therapies for PMS, have led to a growth in the market for pre-menstrual syndrome treatment.

What main market challenges prevent the growth of the pre-menstrual syndrome treatment sector?

The primary obstacles preventing the pre-menstrual syndrome treatment industry from growing are the high cost of creating new treatments and the lack of long-term data on the efficacy and safety of treatments.

What are the main market opportunities for the pre-menstrual syndrome treatment sector?

The potential growth in the pre-menstrual syndrome treatment market might be attributed to the growth of telemedicine, patients now have easier access to medical professionals, and pharmaceutical companies are continuing to innovate with new drug delivery methods like patches and implants.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –